165 related articles for article (PubMed ID: 25230579)
21. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
[TBL] [Abstract][Full Text] [Related]
23. Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
Grünberg J; Lindenblatt D; Dorrer H; Cohrs S; Zhernosekov K; Köster U; Türler A; Fischer E; Schibli R
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1907-15. PubMed ID: 24859811
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cell proliferation, adhesion, and invasion with an anti-L1-cell adhesion molecule monoclonal antibody in an in vitro endometriosis model.
Agic A; von Wussow U; Starzinski-Powitz A; Diedrich K; Altevogt P; Hornung D
Fertil Steril; 2010 Aug; 94(3):1102-4. PubMed ID: 20137787
[TBL] [Abstract][Full Text] [Related]
25. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
[TBL] [Abstract][Full Text] [Related]
26. Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma.
Lindenblatt D; Terraneo N; Pellegrini G; Cohrs S; Spycher PR; Vukovic D; Béhé M; Schibli R; Grünberg J
BMC Cancer; 2018 Sep; 18(1):922. PubMed ID: 30253737
[TBL] [Abstract][Full Text] [Related]
27. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.
Arlt MJ; Novak-Hofer I; Gast D; Gschwend V; Moldenhauer G; Grünberg J; Honer M; Schubiger PA; Altevogt P; Krüger A
Cancer Res; 2006 Jan; 66(2):936-43. PubMed ID: 16424028
[TBL] [Abstract][Full Text] [Related]
28. A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.
Kroesen M; Nierkens S; Ansems M; Wassink M; Orentas RJ; Boon L; den Brok MH; Hoogerbrugge PM; Adema GJ
Int J Cancer; 2014 Mar; 134(6):1335-45. PubMed ID: 24038106
[TBL] [Abstract][Full Text] [Related]
29. Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages.
Meng F; Li C; Li W; Gao Z; Guo K; Song S
IUBMB Life; 2014 Dec; 66(12):835-46. PubMed ID: 25557640
[TBL] [Abstract][Full Text] [Related]
30. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
31. L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer.
Fischer E; Grünberg J; Cohrs S; Hohn A; Waldner-Knogler K; Jeger S; Zimmermann K; Novak-Hofer I; Schibli R
Int J Cancer; 2012 Jun; 130(11):2715-21. PubMed ID: 21796623
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
[TBL] [Abstract][Full Text] [Related]
33. Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization.
Gironella M; Calvo C; Fernández A; Closa D; Iovanna JL; Rosello-Catafau J; Folch-Puy E
Cancer Res; 2013 Sep; 73(18):5682-94. PubMed ID: 23867474
[TBL] [Abstract][Full Text] [Related]
34. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
Abdel-Wahab Z; Darrow T; Vervaert CE; Crowley NJ; Seigler HF
Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
[TBL] [Abstract][Full Text] [Related]
35. L1CAM: Cell adhesion and more.
Samatov TR; Wicklein D; Tonevitsky AG
Prog Histochem Cytochem; 2016 Aug; 51(2):25-32. PubMed ID: 27267927
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.
Zhang J; Yang F; Ding Y; Zhen L; Han X; Jiao F; Tang J
Int J Clin Exp Pathol; 2015; 8(8):9240-7. PubMed ID: 26464672
[TBL] [Abstract][Full Text] [Related]
37. L1 cell adhesion molecule as a therapeutic target in cancer.
Yu X; Yang F; Fu DL; Jin C
Expert Rev Anticancer Ther; 2016; 16(3):359-71. PubMed ID: 26781307
[TBL] [Abstract][Full Text] [Related]
38. A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model.
Lee ES; Jeong MS; Singh R; Jung J; Yoon H; Min JK; Kim KH; Hong HJ
Exp Mol Med; 2012 Apr; 44(4):293-302. PubMed ID: 22248567
[TBL] [Abstract][Full Text] [Related]
39. L1 cell adhesion molecule (L1CAM) in invasive tumors.
Raveh S; Gavert N; Ben-Ze'ev A
Cancer Lett; 2009 Sep; 282(2):137-45. PubMed ID: 19144458
[TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]